Month: August 2025
Revenue achieved $26.7 million, up 34.2% from $19.9 million.
R&D investments totaled $5.8 million, up from $0.8 million in the same period last year.
Net Income was $5.0 million, or $1.19 per share.BEIJING, Aug. 18, 2025 (GLOBE NEWSWIRE) — Global Mofy AI Limited (the “Company” or “Global Mofy”) (Nasdaq: GMM), a generative AI-driven technology solutions provider engaged in virtual technology services and digital assets development for use in the broader digital content industry, today reported its financial results for the six months ended March 31, 2025, showing strong revenue growth of 34.2%, driven by increases in both virtual technology services and digital asset development business lines.
“The revenue growth in the first half of 2025 clearly demonstrates the ongoing efforts and contributions of the Global Mofy team...
AEHL Signs Strategic Agreement with BitGo to Advance Bitcoin Acquisition and Security
Written by Customer Service on . Posted in Public Companies.
New York, NY, Aug. 18, 2025 (GLOBE NEWSWIRE) — Antelope Enterprise Holdings Limited (NASDAQ: AEHL, or the “Company”), today announced that its Bitcoin strategy has officially entered the second phase with the Company signing a formal cooperation agreement with BitGo, a global leader in digital asset custody. Under the agreement, AEHL will complete account opening and Bitcoin purchases on the BitGo platform, with the acquired Bitcoin stored on-chain and safeguarded through a multi-signature private key management mechanism to ensure asset security and compliance.
CEO Ms. Tingting Zhang, stated: “Partnering with BitGo and implementing on-chain storage for Bitcoin represents a key strategic decision by the Company toenhance asset security, transparency, and compliance. BitGo is one of the world’s largest and the leading U.S.-based...
Autonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann & Co. Inc.
Written by Customer Service on . Posted in Public Companies.
Live video webcast on Thursday, August 21st at 1:00 PM ET
Register here
THE WOODLANDS, TX, Aug. 18, 2025 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted treatments, today announced that Brad Hauser, President and Chief Executive Officer will participate in a virtual investor webinar hosted by Ladenburg Thalmann on Thursday, August 21, 2025 and 1:00 PM ET.
The webinar will be moderated by Jeffrey S. Cohen, Managing Director and Director of Equity Research of Ladenburg Thalmann. Following the discussion, there will be a question and answer session. Interested participants may pre-submit questions to events@ladenburg.com ahead of the event.
To register for the webinar, please click here. The webinar will also be accessible...
24/7 concierge: Zoom’s agentic AI and virtual agent now extends to Zoom Phone, helping businesses capture more calls and opportunities
Written by Customer Service on . Posted in Public Companies.
Zoom Virtual Agent expands to Zoom Phone, enabling a new concierge use case that delivers personalized support with agentic concierge capabilities to automate routine calls and streamline frontline service across departments
Zoom AI Companion enhances agentic scheduling to coordinate meetings end-to-end, finding the best time, contacting attendees, tracking responses, and recommending next steps without the back-and-forth
Zoom Hub launches, providing a centralized workspace to create, find, and manage Zoom files
Zoom Team Chat adds AI Companion to mobile for easier catch-up, and quick document summaries without needing to open the file in the Zoom Workplace desktop app, saving time and boosting productivitySAN JOSE, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) — Zoom Communications, Inc. (NASDAQ: ZM) today announced a new concierge...
European Commission Grants Approval of OGSIVEO® (nirogacestat) for the Treatment of Adults with Desmoid Tumors
Written by Customer Service on . Posted in Public Companies.
OGSIVEO is the first and only therapy to receive marketing authorization in the EU for the treatment of desmoid tumors
STAMFORD, Conn., Aug. 18, 2025 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany, announced today that the European Commission (EC) granted marketing authorization for OGSIVEO® (nirogacestat), an oral gamma secretase inhibitor, as monotherapy for the treatment of adults with progressing desmoid tumors who require systemic treatment. OGSIVEO is the first and only therapy approved in the European Union (EU) to treat desmoid tumors.
“Desmoid tumors can have a profound impact on people’s lives and are difficult to manage due to their invasive nature and high rates of recurrence. Until now, there have been no approved medicines in Europe,” said Bernd Kasper, M.D.,...
BNC Expands Holdings to 325,000 BNB, Cementing Its Role as the World’s Largest BNB Treasury
Written by Customer Service on . Posted in Public Companies.
New York, Monday, Aug. 18, 2025 (GLOBE NEWSWIRE) — BNB Network Company (Nasdaq: BNC), the treasury management business of CEA Industries Inc., today announced another major milestone in its treasury strategy, with total holdings now reaching 325,000 BNB, an increase of 125,000 tokens from the initial purchase of 200,000, further solidifying its position as the world’s largest BNB treasury.
This achievement underscores BNC’s conviction in the long-term growth and adoption of the BNB ecosystem. By expanding its holdings to this scale, BNC not only strengthens its balance sheet but also reinforces its commitment to supporting the BNB Chain and driving broader blockchain innovation.
“Reaching 325,000 BNB in our treasury is a powerful statement about where we see the future heading,” said David Namdar, CEO of BNC. “BNB has proven itself...
Navios Maritime Partners L.P. Announces the Date for the Release of Second Quarter Ended June 30, 2025 Results, Conference Call and Webcast
Written by Customer Service on . Posted in Public Companies.
Conference Call & Webcast: Thursday, August 21, 2025 at 8:30 am ET
PIRAEUS, Greece, Aug. 18, 2025 (GLOBE NEWSWIRE) — Navios Maritime Partners L.P. (“Navios Partners”) (NYSE:NMM) announced today that it will host a conference call on Thursday, August 21, 2025 at 8:30 am ET, at which time Navios Partners’ senior management will provide highlights and commentary on earnings results for the second quarter and six months ended June 30, 2025. The Company will report results for the second quarter and six months ended June 30, 2025, prior to the conference call.
A supplemental slide presentation will be available on the Navios Partners website at www.navios-mlp.com under the “Investors” section at 8:00 am ET on the day of the call.
Conference Call details:Call Date/Time: Thursday, August 21, 2025 at...
Safe and Green Development Corporation Reports Over 3,200% Year-Over-Year Revenue Growth in Q2 2025; Resource Group Integration Positions Company for Accelerated Second-Half Performance
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
MIAMI, Aug. 18, 2025 (GLOBE NEWSWIRE) — Safe and Green Development Corporation (NASDAQ: SGD) (“SGD” or the “Company”), a real estate development and environmental solutions company, today announced financial results for the three and six months ended June 30, 2025. The Company delivered $1.4 million in Q2 2025 revenue, representing more than 3,200% growth compared to $42 thousand in Q2 2024. This significant year-over-year increase was driven by the acquisition and integration of Resource Group US Holdings LLC (“Resource Group”), which has expanded SGD’s revenue base and positioned the Company for accelerated performance in the second half of 2025. While the Company has announced that it is evaluating a potential cryptocurrency treasury reserve opportunity that, if consummated, would require the divestiture of Resource Group, no...
Schouw & Co. share buy-back programme, week 33 2025
Written by Customer Service on . Posted in Mergers And Acquisitions.
On 5 May 2025, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 20 of 2 May 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 120 million during the period 5 May to 31 December 2025.
The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).Trading day
No. of shares
Average price
Amount
Accumulated until 8 August 2025
93,400
596.18
55,683,237
Monday, 11 August 2025
1,000
625.84
625,840
Tuesday, 12 August 2025
1,100
631.28
694,408
Wednesday, 13 August 2025
1,100
634.85
698,335
Thursday, 14 August 2025
1,000
633.55
633,550
Friday,...
Pelthos Therapeutics Reports Second Quarter 2025 Financial Results for Legacy Operations and Provides Business Update
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Files Quarterly Report on Form 10-Q detailing financial results for legacy operations for the three and six months ended June 30, 2025Strong physician response following successful launch of ZELSUVMI™ (berdazimer) topical gel 10.3%, the first and only FDA-approved at-home treatment for molluscum contagiosum for patients one year of age and olderCompletes build-out of essential management operational infrastructure and hires 50 territory sales managersDURHAM, N.C., Aug. 18, 2025 (GLOBE NEWSWIRE) — Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company (“Pelthos” or the “Company”) committed to commercializing innovative therapeutic products for high unmet patient needs, today reported financial results for legacy operations for the three and six months ended June 30, 2025. This will be the last...
